Rhythm Pharmaceuticals (RYTM) Change in Receivables (2022 - 2025)
Historic Change in Receivables for Rhythm Pharmaceuticals (RYTM) over the last 4 years, with Q3 2025 value amounting to $6.6 million.
- Rhythm Pharmaceuticals' Change in Receivables rose 28641.69% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.0 million, marking a year-over-year increase of 17179.43%. This contributed to the annual value of $3.6 million for FY2024, which is 5782.71% down from last year.
- Per Rhythm Pharmaceuticals' latest filing, its Change in Receivables stood at $6.6 million for Q3 2025, which was up 28641.69% from $7.8 million recorded in Q2 2025.
- In the past 5 years, Rhythm Pharmaceuticals' Change in Receivables ranged from a high of $7.8 million in Q2 2025 and a low of -$794000.0 during Q4 2024
- For the 4-year period, Rhythm Pharmaceuticals' Change in Receivables averaged around $2.3 million, with its median value being $1.7 million (2024).
- In the last 5 years, Rhythm Pharmaceuticals' Change in Receivables crashed by 34355.83% in 2024 and then soared by 28641.69% in 2025.
- Quarter analysis of 4 years shows Rhythm Pharmaceuticals' Change in Receivables stood at $2.9 million in 2022, then plummeted by 88.74% to $326000.0 in 2023, then crashed by 343.56% to -$794000.0 in 2024, then skyrocketed by 931.23% to $6.6 million in 2025.
- Its Change in Receivables stands at $6.6 million for Q3 2025, versus $7.8 million for Q2 2025 and -$687000.0 for Q1 2025.